G01N 2333/9122
Thymidine kinase
Official title: Thymidine kinase (2.7.1.21)
G01N2333/9122 (Thymidine kinase) appears on 9 US grants and 23 published applications in this corpus.
Search patents in G01N- Granted patents
- 9
- Published applications
- 23
- Assignees
- 8
- Inventors
- 43
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 3 |
| 2015 | 1 | 1 |
| 2016 | 3 | 2 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 4 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 4 |
| 2025 | 1 | 2 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Determination of canine TK1 protein levels17 Mar 2026US 12,578,340 B2Alertix Veterinary Diagnostics AB
- Development of recombinant chicken IgY monoclonal antibody and scFv antibodies raised against human tymidine kinase 1 expressed in mammalian cells and use thereof14 Jan 2025US 12,195,553 B2Sino-Swed Tongkang Bio-Tech (Shenzhen) Limited
- Development of recombinant chicken IGY SCFV antibody raised against human thymidine kinase 1 expressed in prokaryotic cells and use thereof1 Oct 2024US 12,103,980 B2Sino-Swed Tongkang Bio-Tech (Shenzhen) Limited
- Monoclonal anti-TK1 antibodies16 Oct 2018US 10,100,128 B2Arocell AB
- Method and system for detecting and differentiating cancer and sepsis in mammals using biomarkers16 Aug 2016US 9,417,242 B2Veterinary Diagnostics Institute, Inc.
- Ovarian cancer risk prediction13 Aug 2026US 2026/0235608 A1Arocell AB
- Thymidine kinase as a marker for immune checkpoint inhibitor efficacy21 Aug 2025US 2025/0263775 A1
- Chicken-derived recombinant full-length monoclonal igy antibody against human thymidine kinase 1 and applications thereof31 Jul 2025US 2025/0244331 A1Sino-Swed Tongkang Bio-Tech (Shenzhen) Limited
- Predicting cancer relapse29 Aug 2024US 2024/0288432 A1Arocell AB
- Composition and kit for diagnosing cancer and method for diagnosing cancer using same13 Jun 2024US 2024/0192218 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.